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Abstract:  In vitro  cell experiments have been performed to detect and 
monitor the upregulation of intercellular adhesion molecule-1 (ICAM-1) 
and E-selectin simultaneously by photoacoustic molecular imaging (PMI). 
Human umbilical vein endothelial cells (HUVECs) were grown on gelatin-
coated glass slides and stimulated with inflammatory cytokines to induce 
the expression of the inflammatory biomarkers, ICAM-1 and E-selectin. 
Gold nanorods (GNRs) of aspect ratio (AR) 1:3 with absorption centered at 
715 nm conjugated to anti-ICAM-1 antibody and GNRs of AR 1:3.5 with 
absorption centered at 800 nm conjugated to anti-E-selectin were exposed to 
HUVECs with different stimulation conditions. A focused high frequency 
ultrasonic transducer (60 MHz, f/1.5) was used to scan the photoacoustic 
(PA) signal over the top surface of the cell containing slides. Averaged PA 
signal intensity from the stimulated cells was about 3 folds higher (~10 dB) 
compared to the un-stimulated cells for both ICAM-1 and E-selectin. The 
strong binding of GNRs to the stimulated HUVEC cells was evidenced by 
fluorescence imaging. Exposure of HUVEC cells to GNRs conjugated to 
isotype control antibodies confirms a low level non-specific binding. Also, 
at 0, 2, 6, and 24 hours after inflammatory stimulation, the HUVECs were 
exposed to GNRs conjugated anti-ICAM-1 antibody and anti-E-selectin 
antibody. PA intensity at each stage of inflammation compares well with 
fluorescence imaging and rt-PCR quantification. 
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1. Introduction 
Recent reports have shown that inflammation plays a key role in a variety of systemic diseases 
such as atherosclerosis, coronary artery disease (CAD),  rheumatoid arthritis (RA), and 
systemic lupus erythematosus [1]. In the vascular inflammation response, immune cells 
dominate early atherosclerotic lesions, where they activate inflammation, leading to 
progression of the lesions and acute coronary syndromes [1]. Activated immune cells produce 
inflammation primarily through the production of proinflammatory cytokines  [2]. This 
widespread, complex, and multifactorial nature of vascular disease has led cardiovascular 
researchers and clinicians to investigate new strategies for prediction, prevention, and 
treatment [1]. Additionally, endothelial cell dysfunction can also contribute to vascular 
disease by contributing to vasoconstriction, leukocyte adherence, platelet activation, 
mitogenesis, oxidation, thrombosis, impaired coagulation, vascular inflammation, and 
atherosclerosis [3]. Understanding these endothelial cell responses has led to the development 
of diagnostics and therapeutics technology [4]. 
Inflammatory biomarkers may predate clinical disease [5,6].  The importance of the 
inflammatory response in atherosclerosis is indicated by the increased expression of adhesion 
molecules, pro-inflammatory cytokines, and growth factors in lesions and lesion-prone areas 
and by increased resistance to vascular disease in knock-out mice lacking certain cytokines 
[7]. Prospective epidemiological studies have suggested that vascular risk is affected by 
increased basal levels of inflammatory cytokines such as interleukin-6 (IL-6) and tumor 
necrosis factor alpha (TNF-α); cell adhesion molecules such as soluble or membrane-bound 
ICAM-1, E-selectin, and P-selectin; and acute-phase reactants such as C-reactive protein and 
fibrinogen [6]. Detection of these specific biomarkers, especially simultaneously, could show 
the bioactivities of inflammation and may provide prognostic information and further 
characterize systemic diseases such as atherosclerosis. Furthermore, the longitudinal 
monitoring of these transcriptional regulations may lead to a better understanding of 
molecular and cellular processes of diseases. 
It has been shown that photoacoustic molecular imaging (PMI) using nanoparticles as 
targeting agents such as gold nanocages [8], carbon nanotubes [9], gold nano beacons [10], 
and gold nanorods (GNRs) [11–16] can be of value for detection of specific biomarkers of 
interest  in vitro  and  in vivo. In our pervious PMI study, single targeting of vascular 
inflammation biomarker such as ICAM-1 using bio-conjugated GNRs of a fixed aspect ratio 
as targeting agent was demonstrated through in vitro HUVECs cell study and in vivo mouse 
study [17,18]. 
In this study, GNRs of different aspect ratios with optical absorption centered at different 
wavelengths were used to demonstrate simultaneous detection and time course monitoring of 
markers of endothelial inflammation. GNRs were selected for their unique and distinct 
primary absorption peaks at different wavelength depending on their aspect ratio, which 
makes GNRs ideal for multi-target detection. Adhesion molecules, ICAM-1 and E-selectin, 
were chosen as typical biomarker of inflammation and activation of endothelial cells (ECs). 
2. Materials and methods 
2.1. Cell preparations and immunfluorescence analysis 
Human umbilical vein endothelial cells (HUVECs) were maintained on tissue culture plates 
(750ml, BD, Franklin Lakes, NJ, USA) in MCDB131 media (Gibco
®, Invitrogen, Carlsbad, 
CA, USA) supplemented with microvascular EC growth factors (EGM, Cambrex, East 
Rutherford, NJ, USA). Cells were then split into 12 wells of quadriPERM
® (3 × 10
4 cells/well, 
8 mm, Sigma-Aldrich, St. Louis, MO, USA) on the surface gelatin-coated slide (Labscientific, 
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splitting and the cells were left un-stimulated or stimulated with the proinflammatory 
cytokines Interferon-gamma (IFN-γ) (Peprotech, Rocky Hill, NJ, USA) (200 ng/ml) and TNF-
alpha (TNF-α) (Peprotech, Rocky Hill, NJ, USA) (25 ng/ml) for 0, 2, 6 and 24 hours. Cells 
were blocked for 30 min at 4 °C in blocking media (PBS; containing 1% bovine serum 
albumin (BSA) 1% horse serum (HS)). After removing the blocking solution, the cells were 
incubated for 14 hours at 4 °C with gold nanorod-conjugated FITC labeled anti-ICAM-1 
(ebioscience, San Diego, CA, USA) and gold nanorod-conjugated Phycoerythrin (PE) labeled 
anti-E-selectin (ebioscience, San Diego, CA, USA) or isotype control antibody (Biolegend, 
San Diego, CA, USA). Microscope images were subsequently obtained followed by PA 
imaging. For bright field and the fluorescence microscopy measurements, the cells were 
washed 2 times (each time for 5) with PBS. The cells were then fixed in 4% paraformaldehye 
for 4 hours. The fluorescence microscopy was performed using an inverted microscope (X81, 
Olympus, Center Valley, PA, USA) and images were acquired using a CCD camera (DP71, 
Olympus, Center Valley, PA, USA). All images were acquired and processed using identical 
settings [16,19,20]. The EC expression of ICAM-1 and E-selectin was visualized by 
fluorescence imaging. 
2.2. Real-time quantitative PCR 
Real-time PCR (rt-PCR) was performed to quantify expression of ICAM-1 and E-selectin. 
Briefly, HUVEC cells were homogenized and RNA was extracted using Trizol reagent 
(Invitrogen, Carlsbad, CA, USA) as per manufacturer’s instructions and quantified on a 
spectrophotometer (SmartSpec Plus, Bio-Rad, Hercules, CA, USA). mRNA was reverse 
transcribed using Taqman Reverse Transcriptase Reagents (Applied Biosystems, Branchburg, 
NJ, USA) as per manufactures instructions. Real-time PCR was performed on a ABI Prism 
7000 sequence detection system (Applied Biosystems, Foster City, CA, USA) using the 
Absolute Blue SYBR Green kit (Thermo Fischer Scientific, Epsom, Surrey, UK). ICAM-1 
and E-selectin  expression  in  all  samples  was  calculated  by  the  ΔCt  method  as  fold  over 
Glyceraldehyde-3-phosphated dehydrogenase (GAPDH) expression as an internal control. 
ICAM-1 and E-selectin from un-stimulated cells was used as a reference point and fold 
induction of ICAM-1 and E-selectin was determined by dividing the stimulated levels by the 
baseline level. 
2.3. GNRs synthesize and bio-conjugation 
GNRs of aspect ratio (AR) of 1:3 or 1:3.5 were synthesized [21,22]. Their optical absorption 
was centered at 715 nm and 800 nm, respectively, as shown in Fig. 1. As shown, the distinct 
separation in the optical absorption spectrum between GNRs with different ARs enables the 
multiple targeting on the same site with an insignificant overlap between two different 
wavelengths. Synthesized GNRs have a bilayer of surfactant hexadecyltrimethylammonium 
bromide (CTAB) on their surface acting as a stabilizer to prevent aggregation. After removing 
excess CTAB, the GNRs form a pellet at the bottom of the tube, which was redispersed in de-
ionized (DI) water. A layer of polyacrylic acid (PAA) (Sigma-Aldrich, St. Louis, MO, USA) 
was absorbed on the surface of GNRs by adding 100 µl of 10 mg/ml PAA solution to 1 ml of 
GNRs solution. Excess PAA in solution was removed. The layer of PAA provides the -COOH 
functional group required for conjugation. PAA-coated GNRs were dispersed in 10 ml of DI 
water followed by the addition of 1.25 ml of 1M N-ethyl-N-3-dimethylaminopropyl-
carbodiimide (EDC) (Sigma-Aldrich, St. Louis, MO, USA) and 1.25 ml of 1M N-hydroxy-
succinimide (NHS) (Sigma-Aldrich, St. Louis, MO, USA) [23–27]. After 20 min, the reaction 
mixture was added to 20 µl of FITC labeled anti-ICAM-1 antibody or PE labeled anti-E-
selectin antibody. The EDC/NHS mixture forms an active ester intermediate with GNRs 
which undergoes amidation reaction with the -NH2 group in the FITC labeled anti-ICAM-1 
and PE labeled anti-E-selectin antibodies to yield the conjugate. The reaction mixture was 
incubated overnight and then the unconjugated antibody was removed. Un-stimulated or 
stimulated HUVECs were incubated with GNRs conjugated to FITC labeled anti-ICAM-1 or 
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incubated with GNRs alone with no antibody conjugation (blank GNRs) or with fluorescence 
dye labeled anti-IgG conjugated GNRs. These wells serve as controls to estimate nonspecific 
binding levels of GNRs to cells. The concentration of the applied GNRs solution was 10
12 
particles/ml (10
3  particles/pl) prior to the conjugation process for every case. The gelatin 
coated slide was then placed in the sample holder of the PA scanning setup depicted in Fig. 2. 
It should be noted that this concentration is well above the minimum detectable concentration 
of GNRs of ~10
10 particles/ml measured in a very thin (less than 1 mm) gelatin phantom 
under the same experimental conditions as cell experiments, at identical laser fluence (4 
mJ/cm
2). 
 
Fig. 1. Optical absorption spectrum of GNRs with aspect ratio of 1:3 (715 nm) and 1:3.5 (800 
nm) 
2.4. Photoacoustic molecular imaging (PMI) 
Figure 2  illustrates the experimental setup for photoacoustic molecular imaging. Nd:Yag 
pulsed Laser (Quantel, Bozeman, MT, USA) pumps an optical parametric oscillator (OPO, 
Vibrant HE532I, OpoTek, Carlsbad, CA, USA) to generate 5 ns pulses at 10 Hz. The range of 
wavelength was tuned from 680 nm to 950 nm. The laser beam of OPO output was directed to 
illuminate on the surface of cells in the well of the gelatin coated slide (approximately 4 
mJ/cm
2 of fluence for both 715 nm and 800 nm). The slide was held by a sample holder 
connected to  X-Y-Z manual translational stage for positioning. A focused single element 
ultrasonic transducer (LiNbO3, 60 MHz, f / 1.5) was used to detect the PA signal. A 
motorized X-Y translational stage was used to move the transducer to scan horizontally the 
samples. The typical scan area was about 200 µm by 200 µm and the step size was 10-30 µm, 
which is about half of the horizontal beam diameter of the ultrasonic transducer. The PA 
signal was averaged three times at each scanning grid point to minimize the pulse-to-pulse 
energy variation. The ultrasonic transducer output was amplified (model 5900PR, Olympus, 
MA, USA), digitized, and recorded by a digital oscilloscope (WaveSurfer 452, LeCroy Corp., 
NY, USA) synchronized to the laser. The boundary along the circumference and center of 
each individual well (2 mm in diameter) was identified by eye and used as a global marker to 
guide for both fluorescence and PA scanning area. Three sets of PA images were obtained at 
three different locations within this microscopy imaging area of 1000 µm by 700 µm. For PA 
imaging of multiple targets, the laser light was illuminated at different wavelengths, 715 nm 
or 800 nm, on the same samples. The laser light beam size was > 10 mm on the surface of the 
sample, which was large enough to uniformly illuminate the entire sample in the well. 
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Fig. 2. Experimental set up of photoacoustic molecular imaging. Nd:Yag pulsed Laser, 
synchronized to the oscilloscope and pulser/receiver, pumps an optical parametric oscillator to 
generate 5 ns laser pulses at 10 Hz. A focused ultrasonic transducer was used to scan the PA 
signal over the sample in the water tank. 
3. Results and discussion 
Prior to performing multiple targeting experiments, individual single targeting experiments 
were performed on each biomarker in a separate set of the experiments. The PA intensity from 
the stimulated HUVECs was on the average about 8-10 dB higher than the PA intensity from 
the un-stimulated cells for both ICAM-1 and E-selectin. Control experiments using anti-IgG 
conjugated GNRs or blank GNRs on both stimulated and un-stimulated HUVECs confirmed 
low levels of nonspecific binding as measured by PA imaging. PA results in these single 
targeting experiments compare well with fluorescence imaging results and are consistent with 
our previous studies under the similar protocols [17,18,28]. 
With the confirmation of the single targeting of each biomarker, multiple-targeting 
experiments were performed. FITC labeled anti-ICAM-1 bound GNRs and PE labeled anti-E-
selectin bound GNRs solution were mixed, and applied to the stimulated HUVECs. PA 
intensity images and corresponding fluorescence images from the simultaneous targeting of 
ICAM-1 and E-selectin on the surface of HUVECs are presented next to each other in Fig. 3. 
The size of the microscopy image is about 700 µm by 1000 µm. PMI were obtained scanning 
over an area of 200 µm by 200 µm in 10 µm step increments within the microscopy imaging 
area. Three sets of PA images were obtained at different locations within the imaging area 
with similar results. In Fig. 3, the small box in fluorescence image represents the area where 
PA image was believed to be taken around the center of the well and the large box presents 
the maximum possible area of misregistration. In Fig. 3, the left panels present bright field 
((a) common for both ICAM-1 and E-seletin), fluorescence ((b) ICAM-1, (c) E-selectin) and 
PA images ((d) ICAM-1, (e) E-selectin) in stimulated conditions. The right panels present 
bright field ((f) common for both ICAM-1 and E-seletin), fluorescence ((g) ICAM-1, (h) E-
selectin) and PA images ((i) ICAM-1, (j) E-selectin) in un-stimulated conditions. Note that all 
the images of stimulated and un-stimulated cells were obtained from the same batch of the 
cells. Changing the light filter enables visualization of the FITC labeled ICAM-1 anti-body as 
well as the PE labeled E-selectin anti-body, and allows for detection of ICAM-1 and E-
selectin in the same sample. Subsequently the sample slide was positioned in the sample 
holder for PA imaging (See Fig. 2) and by changing wavelengths PA images for ICAM-1 at 
715 nm and E-selectin at 800 nm were obtained. Overall, PA signal intensity from the 
stimulated cells displayed increased expression of ICAM-1 (Fig. 3 (d)) and E-selectin (Fig. 3 
(e)) compared to that from the un-stimulated cells (Fig. 3 (i), (j)). Increased expression of 
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fluorescence images (Fig. 3 (b) and (c) respectively). Note a standard linear interpolation was 
applied to PA raw data in pixels for better presentation. 
 
Fig. 3. Simultaneous photoacoustic molecular imaging of the multiple targeted biomarkers of 
ICAM-1 and E-selectin. The left panels present bright field ((a) common for both ICAM-1 and 
E-seletin), fluorescence ((b) ICAM-1, (c) E-selectin) and PA images ((d) ICAM-1, (e) E-
selectin) in stimulated conditions. The right panels present bright field ((f) common for both 
ICAM-1 and E-seletin), fluorescence ((g) ICAM-1, (h) E-selectin) and PA images ((i) ICAM-1, 
(j) E-selectin) in un-stimulated conditions. The small box in fluorescence image represents the 
area where PA image was believed to be taken around the center of the well and the large box 
presents the maximum possible area of misregistration. Note the image sizes are not scaled. 
In  Fig. 4, PA intensity images along with fluorescence images for control groups are 
presented. The left panels ((a)-(e)) present results for control group in stimulated condition 
and the right panels ((f)-(j)) present results for control group in un-stimulated condition. Note 
the bright field images ((a) stimulated, (f) un-stimulated) are common for both IgG of ICAM-
1 and E-selectin. As a control, GNRs conjugated to either FITC or PE labeled IgG were 
exposed to stimulated cells ((b), (c)) and un-stimulated cells ((g), (h)) in the fluorescence 
images. Corresponding PA images are presented for stimulated cells ((d), (e)) and un-
stimulated cells ((i), (j)). As an additional control, blank GNRs were also exposed to 
stimulated and un-stimulated cells (images not shown). The insignificant PA intensities and 
low brightness of the corresponding fluorescence images in all these controls compared to 
signal generated by ICAM-1 or E-selectin conjugated GNRs in stimulated HUVECs (Fig. 3) 
confirms low levels of nonspecific binding. 
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Fig. 4. Simultaneous photoacoustic molecular imaging of the multiple targeted biomarkers of 
ICAM-1 and E-selectin for control group. The left panels present bright field ((a) common for 
both anti-IgG of ICAM-1 and E-seletin), fluorescence ((b) anti-IgG for ICAM-1, (c) anti-IgG 
for E-seletin) and PA images ((d) anti-IgG for ICAM-1, (e) anti-IgG for E-selectin) in 
stimulated conditions. The right panels present bright field ((f) common for both anti-IgG of 
ICAM-1 and E-seletin), fluorescence ((g) anti-IgG for ICAM-1, (h) anti-IgG for E-seletin) and 
PA images ((i) anti-IgG for ICAM-1, (j) anti-IgG for E-seletin) in un-stimulated conditions. 
The small box in fluorescence image represents the area where PA image was believed to be 
taken around the center of the well and the large box presents the maximum possible area of 
misregistration. Note the image sizes are not scaled. 
The PA intensities depicted in Fig. 3 and 4 are presented in Fig. 5 as average intensity +/− 
standard deviation. Each the PA intensity was averaged over the scanning area of 200 µm by 
200 µm and presented in dB normalized to PA intensity due to exposure of ICAM-1 targeted 
GNRs (Fig. 3 (d)) or E-selectin targeted GNRs (Fig. 3 (e)) to stimulated cells. All images 
were obtained from the same batch of the cells and the cell confluence on each well 
maintained similar in the order of 3 × 10
4  cells/well. Three independent sets of the 
experiments were performed in each case. In Fig. 5, the blue bar in (a) represents PA intensity 
due to exposure of ICAM-1 targeted GNRs to stimulated cells. The red bar in (b) represents 
PA intensity due to exposure of E-selectin targeted GNRs to stimulated cells. The black bars 
are for PA intensity due to exposure of ICAM-1 or E-selectin targeted GNRs to un-stimulated 
cells. Green bars represent PA intensity due to exposure of control group, including IgG-
conjugated GNRs and blank GNRs added to stimulated and un-stimulated cells and cells only. 
On the average, PA intensity from the stimulated cells was about 3 folds (~10 dB) higher than 
that from un-stimulated cells for both ICAM-1 and E-selectin upregulations. Overall, PA 
intensity from the control groups was minimal and comparable to that from ICAM-1or E-
selectin targeted GNRs to un-stimulated cells. 
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Fig. 5. Average PA intensity of the multiple targeted biomarkers of (a) ICAM-1 and (b) E-
selectin. Blue bar: PA intensity due to exposure of ICAM-1 targeted GNRs to stimulated cells. 
Red bar: PA intensity due to exposure of E-selectin targeted GNRs to stimulated cells. Black 
bars: PA intensity due to exposure of ICAM-1or E-selectin targeted GNRs to un-stimulated 
cells. Green bars: PA intensity due to exposure of control group, including IgG-conjugated 
GNRs and blank GNRs added to stimulated and un-stimulated cells and cells only. Standard 
deviation for each group of n = 3 is on top of each scale bar. 
Figure 6 depicts the fluorescence and PA intensity imaging of single targeted biomarker of 
ICAM-1 over time. The upper panels ((a)-(d)) present fluorescence images and the lower 
panels ((e)-(h)) present the corresponding PA intensities at 0, 2, 6, and 24 hours post 
stimulation. Note a standard linear interpolation was applied to PA data in pixels for better 
presentation. It is observed that the overall PA signal intensity level monotonically increases 
as a function of time. The upregulation of ICAM-1 degree at each time point evidenced by 
fluorescence images follow well the corresponding PA intensity changes. 
 
Fig. 6. Time course monitoring of single targeted biomarker of ICAM-1 using fluorescence 
((a)-(d)) and photoacoustic molecular imaging ((e)-(h)) at 0, 2, 6, and 24 hours post 
stimulation. The small box in fluorescence image represents the area where PA image was 
believed to be taken around the center of the well and the large box presents the maximum 
possible area of misregistration. Note the image sizes are not scaled. 
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E-selectin over time. The upper panels ((a)-(d)) present fluorescence images and the lower 
panels ((e)-(h)) present the corresponding PA intensities at 0, 2, 6, and 24 hours post 
stimulation. Compared to ICAM-1, it is observed that the overall PA signal intensity level 
increases and reaches to the peak earlier at t = 6 hours and decreases thereafter as a function 
of time. The upregulation of E-selectin degree at each time point evidenced by fluorescence 
images follow well the corresponding PA intensity changes. 
 
Fig. 7. Time course monitoring of single targeted biomarker of E-selectin using fluorescence 
((a)-(d)) and photoacoustic molecular imaging ((e)-(h)) at 0, 2, 6, and 24 hours post 
stimulation. The small box in fluorescence image represents the area where PA image was 
believed to be taken around the center of the well and the large box presents the maximum 
possible area of misregistration. Note the image sizes are not scaled. 
With the successful monitoring of the single targeting of each biomarker, time course 
monitoring of inflammation markers performed using multi-targeting. Figure 8 represents the 
resulting PA images and fluorescence images of the simultaneous monitoring of ICAM-1 and 
E-selectin. In Fig. 8, the 1st and 3rd columns present fluorescence images monitoring ICAM-
1 and E-selectin respectively, and the 2nd and 4th columns present PA images monitoring 
ICAM-1 and E-selectin respectively. Alternate fluorescence images were obtained for each 
sample by simply changing optical filters and alternate PA images were obtained by changing 
the laser wavelength. Each row in Fig. 8 illustrates the fluorescence and corresponding PA at 
a specific time point after inflammation was stimulated. The first row represents cells upon 
stimulation (t = 0), and rows 2, 3 and 4 contain images from cells stimulated for 2, 6, and 24 
hours respectively. Overall PA signal intensity level changes compare well the brightness 
changes, reflecting the degree of the upregulation of each biomarker, in fluorescence image as 
a function of time (t = 0, 2, 6 and 24 hours post stimulations). 
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Fig. 8. Time course monitoring of multiple targeted biomarkers, ICAM-1 and E-selectin using 
photoacoustic molecular imaging. The left two panels present fluorescence (at t = (a) 0, (e) 2, 
(i) 6, (m) 24 hours) and corresponding PA images (t = (b) 0, (f) 2, (j) 6, (n) 24 hrs) for GNRs 
(715 nm) conjugated anti ICAM-1 and the right two panels present fluorescence (at t = (c)0, 
(g)2, (k)6, (o)24 hrs) and corresponding PA images (at t = (d) 0, (h) 2, (l) 6, (p) 24 hours) for 
GNRs (800 nm) conjugated anti E-selectin at each time point post stimulation. The small box 
in fluorescence image represents the area where PA image was believed to be taken around the 
center of the well and the large box presents the maximum possible area of misregistration. 
Note the image sizes are not scaled. 
The PA intensities depicted in Fig. 8 are presented in Fig. 9 as average intensity +/− 
standard deviation. Three independent sets of the experiments were performed in each case. 
The blue bars (a) represents PA intensity (dB) +/− standard deviation due to exposure of 
ICAM-1 targeted GNRs to the stimulated cells at 0, 2, 6 and 24 hours post stimulation. The 
red bars (b) represent average PA intensity (dB) +/− standard deviation due to exposure of E-
selectin targeted GNRs to the stimulated cells at 0, 2, 6 and 24 hours post stimulation. 
 
Fig. 9. Average PA intensity at each time point post stimulation for multiple targeted 
biomarkers of ICAM-1 and E-selectin. Standard deviation for each group of n = 3 is presented 
on top of each scale bar. 
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represent the over-expression level of ICAM-1 (a) or E-selectin (b) at each time point of post 
stimulation. The over-expression of each gene is expressed as fold-over baseline as a function 
of time +/− standard deviation. 
 
Fig. 10. rt-PCR results of (a) ICAM-1 and (b) E-selectin as function of time   
(Unit; Fold over baseline) 
In summary, the feasibility of the simultaneous detection and monitoring of the multiple 
inflammatory biomarkers such as ICAM-1 and E-selectin on HUVECs was demonstrated in 
vitro. We have demonstrated that PA signal intensity obtained from ICAM-1 and E-selectin 
targeted GNRs exposed to cells changes as a function of the time these cells are exposed to 
inflammatory cytokines, presumably due to increased binding of upregulated cytokines. The 
upregulation of ICAM-1 and E-selectin in these differentially stimulated cells was confirmed 
by the immunofluorescence images and rt-PCR. Control experiments using non-specific IgG-
conjugated GNRs and blank GNRs added to stimulated and un-stimulated cells confirmed the 
absence of significant nonspecific binding. 
Fluorescence imaging of protein levels as well as rt-PCR to detect and quantify mRNA 
levels independently demonstrate large degrees of upregulation of ICAM-1 and E-selectin 
following stimulation. As targeted GNRs are designed to bind to protein, we would 
hypothesize that the relative levels of inflammatory markers as reported by fluorescence 
imaging would most accurately predict PA image intensity, and we have found this to be the 
case in our study. It is important to note that the time course is not identical for both factors, 
and there are subtle differences between the time course reported by fluorescence imaging and 
rt-PCR. ICAM-1 expression both at the protein level (detected by fluorescence imaging) and 
at the mRNA level (detected by rt-PCR) increases over 24 hours. This matches well with data 
reported in [29]. In the case of E-selectin, mRNA levels peak early on (at 2 hours), and active 
protein peaks at 6 hours. This roughly agrees with the protein peak reported in [29] of 4 hours, 
and the mRNA peak reported in [30] of 2-4 hours. It is not surprising to have different 
temporal peaks in mRNA and protein levels as some time is required to translate mRNA into 
protein, which must also be transported to the plasma membrane to become available to bind 
antibody targeted GNRs. We are encouraged to see that the levels of PA intensity match well 
with protein levels over the complete time course of induction of both ICAM-1 and E-
selection, and that these different factors can be monitored simultaneously. 
As one of the limitations of the current setup of the experiments, it should be noted that 
the PMI scanning area was smaller than the fluorescence imaging area due to relatively slow 
scanning time using a single element transducer. The entire area of the fluorescence image 
was first scanned coarsely to confirm uniformity of the PMI signal over the region of interest. 
A smaller PMI area was then chosen with smaller scanning step increments of 10 µm, which 
is about quarter of the beam width of the transducer in the scanning direction. Another 
challenge with the current setup of experiments is achieving exact co-registration, in micron 
scale, between PMI and fluorescence images from two separate systems. With the current 
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imaging setup with confocal capabilities [31,32] would facilitate co-registration in future 
studies or/and potentially enable individual cell imaging. Although the biocompatibility of 
GNRs has known to be favorable compared to other nanoparticles [33], to test the potential 
practical  use of this technique, more thorough study on the cell viability along with PA 
sensitivity using different concentrations of GNRs  are required. In this study, the GNRs 
concentration (10
12 particles/ml) corresponds to about 10000 particles for a cell of 30 microns 
(~10 pl). Based on the minimum detectable concentration of GNRs of ~10
10  particles/ml 
under laser light fluence of 4 mJ/cm
2, about 100 particles per cell can be detected using the 
current system. A recent development of silica coated GNRs might help with improved 
stabilization of the particles and augmented PA sensitivity, reducing the required GNRs dose 
[34]. 
For the potential PMI applications in vascular diseases in vivo, light absorption by blood 
can be a potential problem if the light source is distant from the object to be imaged. This 
limitation might be partially circumvented by the use of an optical fiber light delivery system 
[35], which in conjunction with conventional intravascular ultrasound can access major 
arteries in deep tissues, such as the coronary tree. Early detection of inflammation could lead 
to prompt identification and monitoring of many different diseases. In combination with a 
commercial ultrasound platform, PMI using GNRs as contrast agents may detect 
inflammatory response at very early stages in vivo and potentially monitor the progress of 
inflammation. 
4. Conclusion 
In conclusion, understanding that the upregulation of leukocyte adhesion molecules is 
associated with the process of inflammation and plays a major role in thrombus formation and 
coronary ischemia, specific detection of these biomarkers using bioconjugated gold nanorods 
(GNRs) could enable monitoring of inflammation using the photoacoustic molecular imaging 
(PMI) technique. PMI may be able to detect and monitor endothelial upregulation of 
inflammatory biomarkers in vivo. 
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